Evidence-based approach to the management of sporadic medullary thyroid carcinoma

Jeffrey F. Moley, Elizabeth A. Fialkowski

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


Medullary thyroid carcinoma (MTC) is a rare malignancy of the thyroid C cells. It occurs in hereditary (25% of cases) and sporadic (75%) forms. Sporadic MTCs frequently metastasize to cervical lymph nodes. Thorough surgical extirpation of the primary tumor and nodal metastases by compartment-oriented resection has been the mainstay of treatment (level IV evidence). Surgical resection of residual and recurrent disease is effective in reducing calcitonin levels and controlling complications of central neck disease (level IV evidence). Radioactive iodine, external beam radiation therapy, and conventional chemotherapy have not been effective. Newer systemic treatments, with agents that target abnormal RET proteins hold promise and are being tested in clinical trials for patients with metastatic disease.

Original languageEnglish (US)
Pages (from-to)946-956
Number of pages11
JournalWorld journal of surgery
Issue number5
StatePublished - May 2007
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Evidence-based approach to the management of sporadic medullary thyroid carcinoma'. Together they form a unique fingerprint.

Cite this